abrdn plc
abrdn plc (SLFPY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for abrdn plc (SLFPY), covering cash flow, earnings, and balance sheets.
abrdn plc (SLFPY) Income Statement & Financial Overview
Explore comprehensive income reports for abrdn plc SLFPY, broken down by year and quarter.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $732.00M | $697.00M | $799.00M | $798.00M |
Cost of Revenue | $35.00M | $30.00M | $34.00M | $42.00M |
Gross Profit | $0.00 | $667.00M | $765.00M | $756.00M |
Gross Profit Ratio | $0.00 | $0.96 | $0.96 | $0.95 |
R&D Expenses | $0.00 | $0.00 | $4.00M | $0.00 |
SG&A Expenses | $0.00 | $558.00M | $573.00M | $549.00M |
Operating Expenses | $529.00M | $558.00M | $634.00M | $804.00M |
Total Costs & Expenses | -$608.00M | -$640.00M | -$634.00M | -$804.00M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $13.00M | $12.00M | $13.00M | $12.00M |
Depreciation & Amortization | $63.00M | $59.00M | $61.00M | $65.00M |
EBITDA | $74.00M | $109.00M | $71.00M | $172.00M |
EBITDA Ratio | $0.10 | $0.16 | $0.09 | $0.26 |
Operating Income | $124.00M | $109.00M | $43.00M | $107.00M |
Operating Income Ratio | $0.17 | $0.16 | $0.05 | $0.13 |
Other Income/Expenses (Net) | -$63.00M | $78.00M | $120.00M | -$341.00M |
Income Before Tax | $61.00M | $187.00M | $166.00M | -$173.00M |
Income Before Tax Ratio | $0.08 | $0.27 | $0.21 | -$0.22 |
Income Tax Expense | -$13.00M | $16.00M | $6.00M | -$24.00M |
Net Income | $72.00M | $165.00M | $152.00M | -$151.00M |
Net Income Ratio | $0.10 | $0.24 | $0.19 | -$0.19 |
EPS | $0.04 | $0.09 | $0.09 | -$0.08 |
Diluted EPS | $0.04 | $0.09 | $0.08 | -$0.08 |
Weighted Avg Shares Outstanding | $1.79B | $1.79B | $1.78B | $1.95B |
Weighted Avg Shares Outstanding (Diluted) | $1.82B | $1.82B | $1.95B | $1.95B |
Over the past four quarters, abrdn plc demonstrated steady revenue growth, increasing from $798.00M in Q2 2023 to $732.00M in Q4 2024. Operating income reached $124.00M in Q4 2024, maintaining a consistent 17% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $74.00M, reflecting operational efficiency. Net income dropped to $72.00M, with EPS at $0.04. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan